NEWARK, DE | The clinical diagnostics market was valued at USD 86.5 billion in 2025. Future Market Insights projects the market to expand to USD 91.3 billion in 2026 and reach USD 155.9 billion by 2036, reflecting a steady CAGR of 5.5% over the forecast period. This sustained expansion, delivering an absolute dollar growth of USD 64.6 billion across the decade, underscores...

NEWARK, DE | The Hyperspectral Wound Assessment Imaging Market is valued at USD 72.3 million in 2025 and is projected to reach USD 79.0 million in 2026, expanding at a CAGR of 9.20% through 2036. With increasing clinical reliance on non-contact optical diagnostics to quantify tissue oxygenation and perfusion, the market is expected to achieve USD 190.5 million by 2036. This shift...

NEWARK, DE | The Incontinence Care Products Market, valued at USD 13.5 billion in 2025, is projected to reach USD 14.3 billion in 2026 and grow further to USD 24.8 billion by 2036. This trajectory reflects a compound annual growth rate (CAGR) of 5.7%. The expansion underscores a broader transition toward non-invasive, daily management solutions amid rising chronic conditions and an...

Imagine a high-volume hospital laboratory where test results flow seamlessly from analyzers to clinicians, errors are minimized through automated validation, and laboratory managers gain real-time visibility across multiple sites without wrestling with paper records or fragmented systems. This transformation is no longer a distant vision—it is the new reality for forward-thinking...

NEWARK, DE / April 6, 2026 — The global reusable laparoscopic instruments market is set for steady expansion, growing from USD 5,557.1 million in 2026 to USD 8,712.9 million by 2036, registering a CAGR of 4.6% over the forecast period, according to Future Market Insights (FMI). Growth is being fueled by the widespread adoption of minimally invasive surgical procedures, increasing...

NEWARK, DE | The Self-Amplifying RNA Cancer Immunotherapy Platforms Market was valued at USD 94.0 million in 2025 and is expected to reach USD 112.0 million in 2026. Expanding at a CAGR of 19.10%, the market is projected to achieve USD 643.2 million by 2036. This growth reflects a critical shift in oncology toward dose-sparing RNA technologies that address systemic toxicity...

NEWARK, DE | The SGLT2 inhibitors market was valued at USD 17.8 billion in 2025. According to Future Market Insights analysis, the market is estimated to reach USD 18.9 billion in 2026 and expand to USD 34.5 billion by 2036, reflecting a steady compound annual growth rate (CAGR) of 6.2% during the forecast period. This expansion is propelled by guideline-backed adoption in cardiorenal...